Jana’s Jab at Apple May Be a Route to Reverse Its Shrinking Assets (Bloomberg)
Barry Rosenstein’s push to protect children from overusing iPhones isn’t just about altruism. The managing partner of Jana Partners offered a simple explanation for teaming up with the California State Teachers’ Retirement System this month to urge Apple Inc. to study whether young customers are being hurt. “I don’t think there’s any conflict with generating a positive return” and corporate good, he told CNBC.
Insignia Systems (ISIG) Trading 10.7% Higher Following Insider Buying Activity (The Ledger Gazette)
Insignia Systems, Inc. (NASDAQ:ISIG) shares traded up 10.7% during trading on Wednesday after an insider bought additional shares in the company. The company traded as high as $1.35 and last traded at $1.35. 1,532,800 shares changed hands during mid-day trading, an increase of 202% from the average session volume of 507,670 shares. The stock had previously closed at $1.22.
Insider Buying: Herzfeld Caribbean Basin Fund, Inc (CUBA) Director Buys 10,420 Shares of Stock (TrueBlueTribune)
Herzfeld Caribbean Basin Fund, Inc (NASDAQ:CUBA) Director Thomas J. Herzfeld purchased 10,420 shares of the company’s stock in a transaction dated Thursday, January 18th. The shares were purchased at an average cost of $7.41 per share, for a total transaction of $77,212.20. The transaction was disclosed in a legal filing with the SEC.
Insider Buying: Dell Technologies Inc. (NYSE:DVMT) CEO Acquires 12,967 Shares of Stock (DispatchTribunal)
Dell Technologies Inc. (NYSE:DVMT) CEO Michael S. Dell bought 12,967 shares of the stock in a transaction dated Monday, January 8th. The shares were bought at an average cost of $33.17 per share, with a total value of $430,115.39. Following the completion of the acquisition, the chief executive officer now directly owns 552,241 shares of the company’s stock, valued at approximately $18,317,833.97. The purchase was disclosed in a document filed with the Securities & Exchange Commission.
Insider Buying: Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Major Shareholder Acquires 15,000 Shares of Stock (Stock News Times)
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) major shareholder Michael Rapp acquired 15,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were bought at an average price of $12.99 per share, for a total transaction of $194,850.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Insider Buying: Brave Bison Group PLC (BBSN) Insider Acquires 628,930 Shares of Stock (TrueBlueTribune)
Brave Bison Group PLC (LON:BBSN) insider Paul Campbell-White acquired 628,930 shares of the firm’s stock in a transaction that occurred on Thursday, January 18th. The shares were purchased at an average price of GBX 1 ($0.01) per share, with a total value of £6,289.30 ($8,529.02). Brave Bison Group PLC (BBSN) opened at GBX 0.84 ($0.01) on Friday. The stock has a market cap of $3.51 and a P/E ratio of -84.00. Brave Bison Group PLC has a 1-year low of GBX 0.71 ($0.01) and a 1-year high of GBX 2.93 ($0.04).
